BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 474609 O=c1[nH]c2ccc(Nc3ncnc4sc(CC5CC5)nc34)cc2s1 InChI=1S/C16H13N5OS2/c22-16-20-10-4-3-9(6-11(10)23-16)19-14-13-15(18-7-17-14)24-12(21-13)5-8-1-2-8/h3-4,6-8H,1-2,5H2,(H,20,22)(H,17,18,19) KVTOGWASAODVEB-UHFFFAOYSA-N 176745 US9675612, 1 6-{[2-(Cyclopropylmethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 37 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176745&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321818 363893390 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474610 O=c1[nH]c2ccc(Nc3ncnc4sc(nc34)C3CCC3)cc2s1 InChI=1S/C16H13N5OS2/c22-16-20-10-5-4-9(6-11(10)23-16)19-13-12-15(18-7-17-13)24-14(21-12)8-2-1-3-8/h4-8H,1-3H2,(H,20,22)(H,17,18,19) KLERMRAOMZWPMK-UHFFFAOYSA-N 176746 US9675612, 2 6-[(2-Cyclobutyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 87 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176746&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321819 363893391 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474611 O=c1[nH]c2ccc(Nc3ncnc4sc(nc34)C3CCCCC3)cc2s1 InChI=1S/C18H17N5OS2/c24-18-22-12-7-6-11(8-13(12)25-18)21-15-14-17(20-9-19-15)26-16(23-14)10-4-2-1-3-5-10/h6-10H,1-5H2,(H,22,24)(H,19,20,21) JOBHAMQGNCYJLI-UHFFFAOYSA-N 176747 US9675612, 3 6-[(2-Cyclohexyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 197 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176747&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321820 363893392 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474612 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(Cc3ccccc3)nc12 InChI=1S/C20H16N6OS/c1-27-16-9-14-13(10-23-26-14)8-15(16)24-19-18-20(22-11-21-19)28-17(25-18)7-12-5-3-2-4-6-12/h2-6,8-11H,7H2,1H3,(H,23,26)(H,21,22,24) YVRHMSDAWKCNBE-UHFFFAOYSA-N 176749 US9675612, 4 2-Benzyl-N-(6-methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 20 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176749&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78321821 363893393 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474613 COCc1nc2c(Nc3cc4cn[nH]c4cc3OC)ncnc2s1 InChI=1S/C15H14N6O2S/c1-22-6-12-20-13-14(16-7-17-15(13)24-12)19-10-3-8-5-18-21-9(8)4-11(10)23-2/h3-5,7H,6H2,1-2H3,(H,18,21)(H,16,17,19) NABFBTGSEDBUJN-UHFFFAOYSA-N 176754 US9675612, 5 N-(6-Methoxy-1H-indazol-5-yl)-2-(methoxymethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 25 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176754&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322124 363893397 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474614 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(nc12)C1CCCCC1 InChI=1S/C19H19N5O2S2/c1-26-13-7-12-14(27-19(25)23-12)8-11(13)22-16-15-18(21-9-20-16)28-17(24-15)10-5-3-2-4-6-10/h7-10H,2-6H2,1H3,(H,23,25)(H,20,21,22) YEDGAQYUGFJXFR-UHFFFAOYSA-N 176757 US9675612, 7 6-[(2-Cyclohexyl[1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-5-methoxy-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 354 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176757&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322126 363893399 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474615 C1CCC(CC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H18N6S/c1-2-4-11(5-3-1)17-23-15-16(19-10-20-18(15)25-17)22-13-6-7-14-12(8-13)9-21-24-14/h6-11H,1-5H2,(H,21,24)(H,19,20,22) ZCZORJWUOGQOPQ-UHFFFAOYSA-N 176761 US9675612, 8 2-Cyclohexyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 56 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176761&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322128 363893403 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474616 C(C1CC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C16H14N6S/c1-2-9(1)5-13-21-14-15(17-8-18-16(14)23-13)20-11-3-4-12-10(6-11)7-19-22-12/h3-4,6-9H,1-2,5H2,(H,19,22)(H,17,18,20) CNEUDEVUGXYSLX-UHFFFAOYSA-N 176763 US9675612, 9 2-(Cyclopropylmethyl)-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 36 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176763&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322127 363893405 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474617 C1CC(C1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C16H14N6S/c1-2-9(3-1)15-21-13-14(17-8-18-16(13)23-15)20-11-4-5-12-10(6-11)7-19-22-12/h4-9H,1-3H2,(H,19,22)(H,17,18,20) DYAXDJBXKYCKQQ-UHFFFAOYSA-N 176766 US9675612, 10 2-Cyclobutyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 54 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176766&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322129 363893407 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474618 C(c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1)c1ccccc1 InChI=1S/C19H14N6S/c1-2-4-12(5-3-1)8-16-24-17-18(20-11-21-19(17)26-16)23-14-6-7-15-13(9-14)10-22-25-15/h1-7,9-11H,8H2,(H,22,25)(H,20,21,23) YFLGGBCOCXFXSQ-UHFFFAOYSA-N 176767 US9675612, 11 2-Benzyl-N-(1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 35 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176767&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081876 363893408 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474619 CC1(O)CN(C1)C(=O)CCCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C20H21N7O2S/c1-20(29)9-27(10-20)16(28)4-2-3-15-25-17-18(21-11-22-19(17)30-15)24-13-5-6-14-12(7-13)8-23-26-14/h5-8,11,29H,2-4,9-10H2,1H3,(H,23,26)(H,21,22,24) KHEAIXVLABOYHQ-UHFFFAOYSA-N 176769 US9675612, 12 1-(3-Hydroxy-3-methylazetidin-1-yl)-4-[7-(1H-indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]butan-1-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 173 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176769&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322431 363893410 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474620 CN(C)C(=O)CCCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H19N7OS/c1-25(2)15(26)5-3-4-14-23-16-17(19-10-20-18(16)27-14)22-12-6-7-13-11(8-12)9-21-24-13/h6-10H,3-5H2,1-2H3,(H,21,24)(H,19,20,22) RQIPQFCWMZHYFW-UHFFFAOYSA-N 176770 US9675612, 13 4-[7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-N,N-dimethylbutanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 122 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176770&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324015 363893411 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474621 CC1(O)CN(C1)C(=O)CCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C19H19N7O2S/c1-19(28)8-26(9-19)15(27)5-4-14-24-16-17(20-10-21-18(16)29-14)23-12-2-3-13-11(6-12)7-22-25-13/h2-3,6-7,10,28H,4-5,8-9H2,1H3,(H,22,25)(H,20,21,23) ZOAUVUPYVLBWMI-UHFFFAOYSA-N 176771 US9675612, 14 1-(3-Hydroxy-3-methylazetidin-1-yl)-3-[7-(1H-indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]propan-1-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 126 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176771&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322429 363893412 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474622 COc1cc2[nH]ncc2cc1Nc1ncnc2scnc12 InChI=1S/C13H10N6OS/c1-20-10-3-8-7(4-17-19-8)2-9(10)18-12-11-13(15-5-14-12)21-6-16-11/h2-6H,1H3,(H,17,19)(H,14,15,18) SYJNMKWDALZJGZ-UHFFFAOYSA-N 176772 US9675612, 15 N-(6-Methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 47 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176772&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322430 363893413 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474623 N(c1ccc2[nH]ncc2c1)c1ncnc2scnc12 InChI=1S/C12H8N6S/c1-2-9-7(4-16-18-9)3-8(1)17-11-10-12(14-5-13-11)19-6-15-10/h1-6H,(H,16,18)(H,13,14,17) WEGGSUIYJJSKGU-UHFFFAOYSA-N 176773 US9675612, 16 N-(1H-Indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 186 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176773&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324014 363893414 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474624 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C23H22N6OS/c1-14(2)30-19-11-17-16(12-26-29-17)10-18(19)27-22-21-23(25-13-24-22)31-20(28-21)9-8-15-6-4-3-5-7-15/h3-7,10-14H,8-9H2,1-2H3,(H,26,29)(H,24,25,27) FTJIPXCJVBZCBX-UHFFFAOYSA-N 176774 US9675612, 17 2-(2-Phenylethyl)-N-[6-(propan-2-yloxy)-1H-indazol-5-yl][1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 229 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176774&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081877 363893415 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474625 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2scnc12 InChI=1S/C13H9N5O2S2/c1-20-8-2-7-9(22-13(19)18-7)3-6(8)17-11-10-12(15-4-14-11)21-5-16-10/h2-5H,1H3,(H,18,19)(H,14,15,17) HFHJQINGOOBDPG-UHFFFAOYSA-N 176775 US9675612, 18 5-Methoxy-6-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 104 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176775&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322432 363893416 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474626 O=c1[nH]c2ccc(Nc3ncnc4scnc34)cc2s1 InChI=1S/C12H7N5OS2/c18-12-17-7-2-1-6(3-8(7)20-12)16-10-9-11(14-4-13-10)19-5-15-9/h1-5H,(H,17,18)(H,13,14,16) UJZFMVNJBQCZEK-UHFFFAOYSA-N 176776 US9675612, 19 6-([1,3]Thiazolo[5,4-d]pyrimidin-7-ylamino)-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 159 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176776&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322435 363893417 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474627 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(COCc3ccccc3)nc12 InChI=1S/C21H18N6O2S/c1-28-17-8-15-14(9-24-27-15)7-16(17)25-20-19-21(23-12-22-20)30-18(26-19)11-29-10-13-5-3-2-4-6-13/h2-9,12H,10-11H2,1H3,(H,24,27)(H,22,23,25) BULRVIAVJLIGCX-UHFFFAOYSA-N 176777 US9675612, 20 2-[(Benzyloxy)methyl]-N-(6-methoxy-1H-indazol-5-yl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 36 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176777&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322434 363893418 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474628 CN(C)C(=O)CCc1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C17H17N7OS/c1-24(2)14(25)6-5-13-22-15-16(18-9-19-17(15)26-13)21-11-3-4-12-10(7-11)8-20-23-12/h3-4,7-9H,5-6H2,1-2H3,(H,20,23)(H,18,19,21) KEYAXZNNOKHTNA-UHFFFAOYSA-N 176778 US9675612, 21 3-[7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-N,N-dimethylpropanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 100 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176778&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78324013 363893419 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474629 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C21H18N6OS/c1-28-17-10-15-14(11-24-27-15)9-16(17)25-20-19-21(23-12-22-20)29-18(26-19)8-7-13-5-3-2-4-6-13/h2-6,9-12H,7-8H2,1H3,(H,24,27)(H,22,23,25) SAVRDDXYWDOTBR-UHFFFAOYSA-N 176779 US9675612, 22 N-(6-Methoxy-1H-indazol-5-yl)-2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 38 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176779&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081878 363893420 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474630 C(Cc1ccccc1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C20H16N6S/c1-2-4-13(5-3-1)6-9-17-25-18-19(21-12-22-20(18)27-17)24-15-7-8-16-14(10-15)11-23-26-16/h1-5,7-8,10-12H,6,9H2,(H,23,26)(H,21,22,24) PHURRAYIJKZDIK-UHFFFAOYSA-N 176780 US9675612, 23 N-(1H-indazol-5-yl)-2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-amine Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 51 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176780&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 133081879 363893421 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474631 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(CCc3ccccc3)nc12 InChI=1S/C21H17N5O2S2/c1-28-15-9-14-16(29-21(27)25-14)10-13(15)24-19-18-20(23-11-22-19)30-17(26-18)8-7-12-5-3-2-4-6-12/h2-6,9-11H,7-8H2,1H3,(H,25,27)(H,22,23,24) PDQZQTBABJNURP-UHFFFAOYSA-N 176782 US9675612, 25 5-Methoxy-6-{[2-(2-phenylethyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 10000 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176782&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322753 363893422 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474632 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(CCCC(=O)N(C)C)nc12 InChI=1S/C19H21N7O2S/c1-26(2)16(27)6-4-5-15-24-17-18(20-10-21-19(17)29-15)23-13-7-11-9-22-25-12(11)8-14(13)28-3/h7-10H,4-6H2,1-3H3,(H,22,25)(H,20,21,23) LOQIDZDIKMNNIH-UHFFFAOYSA-N 176783 US9675612, 26 4-{7-[(6-Methoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}-N, N-dimethylbutanamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 85 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176783&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322754 363893423 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474633 CN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C15H12N6O2S2/c1-21(2)14(22)13-20-10-11(16-6-17-12(10)25-13)18-7-3-4-8-9(5-7)24-15(23)19-8/h3-6H,1-2H3,(H,19,23)(H,16,17,18) JBLDGANSEOAEBH-UHFFFAOYSA-N 176784 US9675612, 27 N,N-Dimethyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 408 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176784&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322755 363893424 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474634 COc1cc2[nH]c(=O)sc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C16H14N6O3S2/c1-22(2)15(23)14-21-11-12(17-6-18-13(11)27-14)19-7-5-10-8(4-9(7)25-3)20-16(24)26-10/h4-6H,1-3H3,(H,20,24)(H,17,18,19) WHXOJFLHDLEWEL-UHFFFAOYSA-N 176785 US9675612, 28 7-[(5-Methoxy-2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino]-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 1080 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176785&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78322756 363893425 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474635 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C16H15N7O2S/c1-23(2)16(24)15-21-12-13(17-7-18-14(12)26-15)20-10-4-8-6-19-22-9(8)5-11(10)25-3/h4-7H,1-3H3,(H,19,22)(H,17,18,20) OJTUGJMQDUSDMJ-UHFFFAOYSA-N 176790 US9675612, 29 7-[(6-Methoxy-1H-indazol-5-yl)amino]-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 199 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176790&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323062 363893426 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474636 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C17H17N7O2S/c1-4-26-12-6-10-9(7-20-23-10)5-11(12)21-14-13-15(19-8-18-14)27-16(22-13)17(25)24(2)3/h5-8H,4H2,1-3H3,(H,20,23)(H,18,19,21) WRSLSMOUHFZACQ-UHFFFAOYSA-N 176791 US9675612, 30 7-[(6-Ethoxy-1H-indazol-5-yl)amino]-N, N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 42 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176791&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323063 363893427 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474637 O=C(N1CCCCC1)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H17N7OS/c26-18(25-6-2-1-3-7-25)17-23-14-15(19-10-20-16(14)27-17)22-12-4-5-13-11(8-12)9-21-24-13/h4-5,8-10H,1-3,6-7H2,(H,21,24)(H,19,20,22) GTZGLKDMQAHUTP-UHFFFAOYSA-N 176793 US9675612, 31 [7-(1H-Indazol-5-ylamino)[1,3]thiazolo[5,4-d]pyrimidin-2-yl](piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 188 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176793&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323716 363893428 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474638 O=C(N1CCCCC1)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C18H16N6O2S2/c25-17(24-6-2-1-3-7-24)16-23-13-14(19-9-20-15(13)28-16)21-10-4-5-11-12(8-10)27-18(26)22-11/h4-5,8-9H,1-3,6-7H2,(H,22,26)(H,19,20,21) FSGSASMAGXXRPZ-UHFFFAOYSA-N 176794 US9675612, 32 6-{[2-(Piperidin-1-ylcarbonyl)[1,3]thiazolo[5,4-d]pyrimidin-7-yl]amino}-1,3-benzothiazol-2(3H)-one Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 137 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176794&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323064 363893429 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474639 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C19H19N7O2S/c1-28-14-8-12-11(9-22-25-12)7-13(14)23-16-15-17(21-10-20-16)29-18(24-15)19(27)26-5-3-2-4-6-26/h7-10H,2-6H2,1H3,(H,22,25)(H,20,21,23) AUDXHTGDNOKTJE-UHFFFAOYSA-N 176795 US9675612, 33 {7-[(6-Methoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}(piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 17 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176795&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78209989 363893430 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474640 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C20H21N7O2S/c1-2-29-15-9-13-12(10-23-26-13)8-14(15)24-17-16-18(22-11-21-17)30-19(25-16)20(28)27-6-4-3-5-7-27/h8-11H,2-7H2,1H3,(H,23,26)(H,21,22,24) XXQQLBYIKZQGJQ-UHFFFAOYSA-N 176796 US9675612, 34 {7-[(6-Ethoxy-1H-indazol-5-yl)amino][1,3]thiazolo[5,4-d]pyrimidin-2-yl}(piperidin-1-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 34 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176796&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323065 363893431 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474641 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N1CCCCC1 InChI=1S/C21H23N7O2S/c1-12(2)30-16-9-14-13(10-24-27-14)8-15(16)25-18-17-19(23-11-22-18)31-20(26-17)21(29)28-6-4-3-5-7-28/h8-12H,3-7H2,1-2H3,(H,24,27)(H,22,23,25) IWFOIBXHQBGDSE-UHFFFAOYSA-N 176798 US9675612, 35 Piperidin-1-yl(7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidin-2-yl)methanone Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 102 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176798&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323066 363893432 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474642 CN(C)C(=O)CN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C18H18N8O2S/c1-25(2)13(27)8-26(3)18(28)17-23-14-15(19-9-20-16(14)29-17)22-11-4-5-12-10(6-11)7-21-24-12/h4-7,9H,8H2,1-3H3,(H,21,24)(H,19,20,22) YENCYEMLPGOTLV-UHFFFAOYSA-N 176799 US9675612, 36 N-[2-(Dimethylamino)-2-oxoethyl]-7-(1H-indazol-5-ylamino)-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 81 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176799&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323067 363893433 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474643 CN(C)C(=O)CN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C18H17N7O3S2/c1-24(2)12(26)7-25(3)17(27)16-23-13-14(19-8-20-15(13)30-16)21-9-4-5-10-11(6-9)29-18(28)22-10/h4-6,8H,7H2,1-3H3,(H,22,28)(H,19,20,21) WPRLGOAWHDQXCW-UHFFFAOYSA-N 176800 US9675612, 37 N-[2-(Dimethylamino)-2-oxoethyl]-N-methyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 445 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176800&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323384 363893434 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474644 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C19H20N8O3S/c1-26(2)14(28)8-27(3)19(29)18-24-15-16(20-9-21-17(15)31-18)23-12-5-10-7-22-25-11(10)6-13(12)30-4/h5-7,9H,8H2,1-4H3,(H,22,25)(H,20,21,23) YUXHVQMBKVZDJF-UHFFFAOYSA-N 176801 US9675612, 38 N-[2-(Dimethylamino)-2-oxoethyl]-7-[(6-methoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 136 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176801&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323385 363893435 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474645 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C21H24N8O3S/c1-11(2)32-15-7-13-12(8-24-27-13)6-14(15)25-18-17-19(23-10-22-18)33-20(26-17)21(31)29(5)9-16(30)28(3)4/h6-8,10-11H,9H2,1-5H3,(H,24,27)(H,22,23,25) RHFZKVJUBNIYGR-UHFFFAOYSA-N 176802 US9675612, 39 N-[2-(Dimethylamino)-2-oxoethyl]-N-methyl-7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 98 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176802&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323386 363893436 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474646 CN(C)C(=O)CCN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C19H20N8O2S/c1-26(2)14(28)6-7-27(3)19(29)18-24-15-16(20-10-21-17(15)30-18)23-12-4-5-13-11(8-12)9-22-25-13/h4-5,8-10H,6-7H2,1-3H3,(H,22,25)(H,20,21,23) CFCGCECRYDIIIU-UHFFFAOYSA-N 176803 US9675612, 40 N-[3-(Dimethylamino)-3-oxopropyl]-7-(1H-indazol-5-ylamino)-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 49 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176803&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323387 363893437 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474647 CN(C)C(=O)CCN(C)C(=O)c1nc2c(Nc3ccc4[nH]c(=O)sc4c3)ncnc2s1 InChI=1S/C19H19N7O3S2/c1-25(2)13(27)6-7-26(3)18(28)17-24-14-15(20-9-21-16(14)31-17)22-10-4-5-11-12(8-10)30-19(29)23-11/h4-5,8-9H,6-7H2,1-3H3,(H,23,29)(H,20,21,22) QPOFDDVJEAKYFR-UHFFFAOYSA-N 176804 US9675612, 41 N-[3-(Dimethylamino)-3-oxopropyl]-N-methyl-7-[(2-oxo-2,3-dihydro-1,3-benzothiazol-6-yl)amino][1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 2750 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176804&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323389 363893438 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474648 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C21H24N8O3S/c1-5-32-15-9-13-12(10-24-27-13)8-14(15)25-18-17-19(23-11-22-18)33-20(26-17)21(31)29(4)7-6-16(30)28(2)3/h8-11H,5-7H2,1-4H3,(H,24,27)(H,22,23,25) WPIYERCLBJHUFT-UHFFFAOYSA-N 176805 US9675612, 42 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-ethoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 125 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176805&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323388 363893439 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474649 CN(C)C(=O)c1nc2c(Nc3ccc4[nH]ncc4c3)ncnc2s1 InChI=1S/C15H13N7OS/c1-22(2)15(23)14-20-11-12(16-7-17-13(11)24-14)19-9-3-4-10-8(5-9)6-18-21-10/h3-7H,1-2H3,(H,18,21)(H,16,17,19) DSGSLUOZFVMIEG-UHFFFAOYSA-N 176806 US9675612, 43 7-(1H-Indazol-5-ylamino)-N,N-dimethyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 202 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176806&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323715 363893440 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474650 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)C InChI=1S/C18H19N7O2S/c1-9(2)27-13-6-11-10(7-21-24-11)5-12(13)22-15-14-16(20-8-19-15)28-17(23-14)18(26)25(3)4/h5-9H,1-4H3,(H,21,24)(H,19,20,22) GZOIWXBZLNFSOM-UHFFFAOYSA-N 176807 US9675612, 44 N,N-Dimethyl-7-{[6-(propan-2-yloxy)-1H-indazol-5-yl]amino}[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 52 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176807&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323711 363893441 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474651 CCOc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CC(=O)N(C)C InChI=1S/C20H22N8O3S/c1-5-31-14-7-12-11(8-23-26-12)6-13(14)24-17-16-18(22-10-21-17)32-19(25-16)20(30)28(4)9-15(29)27(2)3/h6-8,10H,5,9H2,1-4H3,(H,23,26)(H,21,22,24) KDZDBRGGLATXJY-UHFFFAOYSA-N 176808 US9675612, 45 N-[2-(Dimethylamino)-2-oxoethyl]-7-[(6-ethoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 57 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176808&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323714 363893442 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474652 COc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C20H22N8O3S/c1-27(2)15(29)5-6-28(3)20(30)19-25-16-17(21-10-22-18(16)32-19)24-13-7-11-9-23-26-12(11)8-14(13)31-4/h7-10H,5-6H2,1-4H3,(H,23,26)(H,21,22,24) RHMWHKLMOIVTHU-UHFFFAOYSA-N 176810 US9675612, 46 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-methoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 184 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176810&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323712 363893443 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 474653 CC(C)Oc1cc2[nH]ncc2cc1Nc1ncnc2sc(nc12)C(=O)N(C)CCC(=O)N(C)C InChI=1S/C22H26N8O3S/c1-12(2)33-16-9-14-13(10-25-28-14)8-15(16)26-19-18-20(24-11-23-19)34-21(27-18)22(32)30(5)7-6-17(31)29(3)4/h8-12H,6-7H2,1-5H3,(H,25,28)(H,23,24,26) SLXIXSQVDODQRE-UHFFFAOYSA-N 176814 US9675612, 47 N-[3-(Dimethylamino)-3-oxopropyl]-7-[(6-isopropoxy-1H-indazol-5-yl)amino]-N-methyl[1,3]thiazolo[5,4-d]pyrimidine-2-carboxamide Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 344D] Human 32 7.5 US Patent 10.7270/Q2RN3612 aid1794997 US9675612 Klar, U; Wortmann, L; Graham, K; Puehler, F; Sulzle, D; Kettschau, G; Lienau, P 6/13/2017 4/12/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=176814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=371&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=176814&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29+344D%5D&column=ki&startPg=0&Increment=50&submit=Search 78323713 363893444 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPDPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6